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Abstract.
Background: Studies of physical exercise in patients with Alzheimer’s disease (AD) are few and results have been inconsistent.
Objective: To assess the effects of a moderate-to-high intensity aerobic exercise program in patients with mild AD.
Methods: In a randomized controlled trial, we recruited 200 patients with mild AD to a supervised exercise group (60-min
sessions three times a week for 16 weeks) or to a control group. Primary outcome was changed from baseline in cognitive
performance estimated by Symbol Digit Modalities Test (SDMT) in the intention-to-treat (ITT) group. Secondary outcomes
included changes in quality of life, ability to perform activities of daily living, and in neuropsychiatric and depressive symptoms.
Results: The ITT analysis showed no significant differences between intervention and control groups in change from baseline of
SDMT, other cognitive tests, quality of life, or activities of daily living. The change from baseline in Neuropsychiatric Inventory
differed significantly in favor of the intervention group (mean: –3.5, 95% confidence interval (CI) –5.8 to –1.3, p = 0.002). In
subjects who adhered to the protocol, we found a significant effect on change from baseline in SDMT as compared with the
control group (mean: 4.2, 95% CI 0.5 to 7.9, p = 0.028), suggesting a dose-response relationship between exercise and cognition.
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Conclusions: This is the first randomized controlled trial with supervised moderate-to-high intensity exercise in patients with
mild AD. Exercise reduced neuropsychiatric symptoms in patients with mild AD, with possible additional benefits of preserved
cognition in a subgroup of patients exercising with high attendance and intensity.
Keywords: Alzheimer’s disease, behavioral symptoms, cognition, exercise, randomized controlled trial
INTRODUCTION
The number of people living with Alzheimer’s dis-
ease (AD) is growing due to increasing life expectancy.
The effect of pharmacological treatment is limited, and
no new drugs have been approved in the last decade
[1]. There is an urgent need for alternative treatments,
including non-pharmacological approaches.
Various longitudinal cohort studies have suggested
that physical activity in middle age protects against
cognitive decline and dementia in old age [2, 3] and
preserves the ability to perform activities of daily liv-
ing (ADL) among older healthy subjects [4]. Moreover,
a dose-response has been suggested in healthy sub-
jects showing that higher levels of physical activity are
associated with better cognitive performance [5]. How-
ever, a recent large randomized trial in sedentary adults
failed to show any effect on cognitive outcomes after
24 months of moderate intensity physical exercise [6].
Almost all randomized studies in patients with mild
cognitive impairment (MCI) demonstrate some pos-
itive effects on one or several domains of cognition
[7]. In one of the largest randomized trials of aerobic
exercise in MCI subjects, tests of executive function
(Symbol Digit Modalities, Verbal Fluency, and Stroop)
showed improvement, whereas memory tests did not,
suggesting that certain cognitive domains are more
amendable to exercise than others [8]. In studies of
dementia and AD, one recent review [7] and an updated
meta-analysis [9] underscore the need for caution in
interpreting findings due to methodological issues.
Further, some studies in patients with AD or MCI
have relied on unsupervised, caregiver supervised, or
partly unsupervised exercise [8, 10, 11]. Problems with
small samples sizes, inadequate randomization proce-
dures, and a lack of sufficient measures of exercise
intensity also underscore the need for more rigorously
conducted research in this area [7].
Although exercise may yield benefits in quality of
life and neuropsychiatric and depressive symptoms in
patients with AD, a recent meta-analysis concluded
that there was not much evidence for such an effect
[9]. None of the studies on neuropsychiatric symp-
toms involved community-dwelling patients, which is
a critical issue, as these symptoms are the primary
cause of caregiver burden and later nursing home
placement [12].
To our knowledge this is the first study to investi-
gate the potential benefits of continuously supervised
moderate-to-high intensity aerobic exercise on cog-
nition, neuropsychiatric and depressive symptoms,
health-related quality of life and ADL, in community-
dwelling patients with mild AD.
MATERIAL AND METHODS
Study design
The Preserving Cognition, Quality of Life, Phys-
ical Health and Functional Ability in Alzheimer’s
Disease: The Effect of Physical Exercise (ADEX)
study was a multi-center, single-blind, randomized trial
conducted between January 2012 and June 2014. Par-
ticipants were randomized to a control group, which
received treatment as usual, or an intervention group,
which performed 60 min of supervised moderate-to-
high intensity aerobic exercise three times weekly for
16 weeks. An uncontrolled pilot study was carried out
in 2011 [13] to ensure the acceptability, safety, and
feasibility of the intervention, as recommended in the
Medical Research Council’s guidelines for complex
interventions [14]. A detailed description of the meth-
ods of the study has previously been published [15].
Ethical approval
The trial protocol was approved by the Danish
National Committee on Biomedical Research Ethics
(H-3-2011-128) and written informed consent was
obtained from all participants. The Danish Data Pro-
tection Agency approved the research database (ID No
30-0718).
Study participants
Two-hundred community-dwelling patients with
mild AD were included. All patients had a clinical
diagnosis of probable AD according to the NINDS-
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ADRDA Alzheimer’s Criteria [16]. Subjects were
recruited from eight outpatient memory clinics in
Denmark. All sites listed in the acknowledgment par-
ticipated in the data collection.
Inclusion criteria included a Mini Mental State
Examination (MMSE) score >19 (at screening less
than six weeks prior to baseline visit), age between
50–90 years, and a caregiver with regular contact (more
than once a month) who was willing to participate in
the study. If patients received anti-dementia medica-
tion or mood stabilizing medication, they had to be on
a stable dose for at least three months before inclusion.
Exclusion criteria were 1) presence of cardiac or
other medical diseases constituting a contraindication
to physical activity or other neurological diseases caus-
ing cognitive decline (including severe cerebrovascular
disease judged from cranial computed tomography or
magnetic resonance imaging); 2) severe psychiatric
disease; 3) alcohol abuse within the last two years
according to the national guidelines; and 4) participa-
tion in regular physical activity of high intensity two or
more times weekly. Detailed inclusion and exclusion
criteria have previously been described [15].
Study procedures
Participants were included every six months over
a period of 2.5 years. After screening for eligibility
and obtaining informed consent, assessors (blinded to
the group assignment throughout the study period)
completed the baseline assessments. Subsequently,
participants were randomized in blocks of 4–10 per
participating center, using a computerized random-
number generator. In the case of an unequal number
of participants in one center, randomization was set up
to favor the intervention group. Patients who discontin-
ued participating in the intervention were encouraged
to participate in the follow-up visit.
Intervention group
Three weekly exercise sessions were conducted in
a group of 2–5 participants supervised by an experi-
enced physiotherapist. The first four weeks of exercise
(adaption) emphasized getting used to exercising and
building up strength, primarily of the lower extremi-
ties (twice weekly). Participants were also introduced
to aerobic exercise (once weekly). For the remain-
ing 12 weeks, patients performed aerobic exercise of
moderate-to-high intensity (in total 3 × 10 min on an
ergometer bicycle, cross trainer, and treadmill with
2–5 min rest between). Average heart rate (HR) was
registered using continuous monitoring during aerobic
exercise, including the rest intervals. The target inten-
sity was 70–80% of maximal HR (220 - the person’s
age). To ensure that participants exercised with the
intended intensity throughout the training period, aver-
age HR was further calculated for three time periods
(between weeks 4 to 8, 8 to 12, and 12 to 16) as: (aver-
age HR of all sessions in a 4-week period)/(maximal
HR) [17]. The training log also included information
about training instruments and attendance. Attendance
rate was defined as: (total number of attended training
sessions)/(total number of offered training sessions).
Control group
Participants assigned to the control group received
treatment as usual with access to memory clinic staff
if medical or other needs necessitated contact during
the study period. In order to increase adherence and
positive expectations to the study, all control group
subjects were offered 4 weeks of adaptation exercise
after the termination of the study.
Outcomes
The primary outcome measure was the Symbol Digit
Modalities Test (SDMT) [18], which assesses mental
speed and attention. Using the number and symbol key
at the top of the test page, participants were asked to
correctly decode several lines of symbols. The total
number of correct decodings in 120 s was used as
outcome. Secondary outcome measures comprised of
the Alzheimer’s Disease Assessment Scale – Cogni-
tive Subscale (ADAS-Cog) verbal memory test [19]
(10 words recalled three times, immediate and delayed
recall); the Stroop Color and Word Test (Stroop) [20]
incongruent score; verbal fluency (number of words
beginning with F, A, S, and animals named for 1 min
each); and the MMSE [21]. The Hamilton Depression
Rating Scale 17 items (HAMD-17) [22] was used to
rate the severity of depressive symptoms.
Caregiver questionnaires included the Alzheimer’s
Disease Cooperative Study–Activities of Daily Living
Inventory (ADCS–ADL) [23] scale and the 12-item
Neuropsychiatric Inventory (NPI-12) [24].
The European Quality of Life–5 Dimensions (EQ-
5D) [25] health-related quality of life scale, which
includes a visual analogue scale (EQ-5D VAS), was
administered to both caregiver and patient [26].
All raters performing the outcome measurements
were blinded to group assignment, and patients and
caregivers were advised not to disclose group assign-
ment during the test sessions.
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Fig. 1. Flow diagram of the ADEX study. Study participation and follow-up including reasons for drop-out.
Statistical analysis
Sociodemographic characteristics, baseline comor-
bidities, and medicine use, as well as the outcome
measures at baseline, were compared between random-
ization groups using the Wilcoxon signed rank test
for continuous variables and Fisher’s exact tests for
categorical variables.
The differences in change in outcomes from base-
line to follow-up at 16 weeks between randomization
groups were analyzed in linear regression models
using generalized estimating equations to account for
repeated measurement. Memory clinic and group indi-
cator variables were included in the models to account
for possible clustering by training groups. Missing data
may have different causes for the two randomization
groups and to avoid the associated bias, the measure-
ments available at follow-up were weighted by the
inverse of an estimate of the probability of still being in
the study [27]. These probabilities were estimated from
the data in a logistic regression model with the patient’s
baseline characteristics and the observed outcome at
baseline as covariates. In the analysis of secondary
outcomes, multiple comparisons were adjusted for by
controlling the false discovery rate at 5% [28].
In addition to intention-to-treat (ITT) analyses, we
analyzed outcomes in a per protocol population (high
exercise subjects), defined as participants in the inter-
vention arm with a training attendance of more than
80% and average training intensity of more than 70%
of maximal HR. The per protocol definition was set
a priori based on previously accepted compliance
thresholds applied in pharmaceutical trials [29] and on
the lower limit of the intended intensity level. Because
this analysis was exploratory, no correction for multi-
ple comparisons was applied.
RESULTS
Participant baseline characteristics
Of the 608 individuals screened for eligibility, 200
were randomized and included in the ITT analysis
(Fig. 1). There were no significant differences in base-
line characteristics between the intervention group and
the control group in any of the parameters (Table 1).
One-hundred and thirteen were males (57%), subjects
had a mean age of 70.5 years, and a mean MMSE
score of 24.0. A total of 190 (96%) subjects com-
pleted follow-up. Eighty-one of 107 participants in
the intervention group (76%) attended more than 80%
of the exercise sessions; 83 subjects (78%) exercised
with an intensity of more than 70% of maximal HR
during the exercise sessions; and 66 subjects (62%) ful-
filled both criteria (high exercise subjects). There were
no significant differences in baseline demographics
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Table 1
Baseline demographic and clinical characteristics of the study population
Control Intervention Total
N (%) 93 (46.5%) 107 (53.5%) 200 (100%) range
Sociodemographics
Gender, n (%)
Women 36 (38.7) 51 (47.7) 87 (43.5)
Men 57 (61.3) 56 (52.3) 113 (56.5)
Age (years), mean (SD) 71.3 (7.3) 69.8 (7.4) 70.5 (7.4)
Caregiver living with patient, n (%) 66 (71.0) 78 (72.9) 144 (72.0)
Physical Activity Scale for the Elderly*, mean (SD) 97.2 (49.0) 95.2 (41.6) 96.5 (45.1)
Comorbidities
Hypertension, n (%) 35 (37.6) 48 (44.9) 83 (41.5)
Diabetes, n (%) 7 (7.5) 11 (10.3) 18 (9.0)
Hypercholesterolemia, n (%) 34 (36.6) 40 (37.4) 74 (37.0)
Stroke, n (%) 2 (2.2) 1 (0.9) 3 (1.5)
Acute myocardial infarction, n (%) 1 (1.1) 2 (1.9) 3 (1.5)
Medicine
Antihypertensive treatment, n (%) 39 (41.9) 48 (44.9) 87 (43.5)
Antidepressants, n (%) 28 (30.1) 29 (27.1) 57 (28.5)
Anti-Alzheimer’s treatment, n (%) 88 (94.6) 105 (98.1) 193 (96.5)
Beta-blocker treatment, n (%) 9 (9.7) 7 (6.5) 16 (8.0)
Symbol Digit Modalities Test§, mean (SD) 25.4 (14.3) 27.1 (14.7) 26.7 (14.5) 0–63
Mini Mental State Examination¶, mean (SD) 24.1 (3.8) 23.8 (3.4) 24.0 (3.6) 14–30
Hamilton Depression Rating Scale 17 items†, mean (SD) 2.0 (2.5) 1.9 (2.6) 2.0 (2,6) 0–11
Neuropsychiatric Inventory ‡, mean (SD) 9.4 (9.7) 10.0 (10.8) 9.7 (10.3) 0–42
Fisher’s exact test was used for categorical variables and Wilcoxon signed-rank test was used for continuous variables; there were no significant
between-group differences in any baseline characteristics. *Physical activity was measured by means of the Physical Activity Scale for the
Elderly [41] (derived by multiplying activity participation by established item weights). Higher scores indicate higher levels of habitual physical
activity.§Scores on the Symbol Digit Modalities Test are the number of correct matches in 120 s, with a higher score indicating a higher level
of mental speed and attention.¶Scores on the Mini–Mental State Examination range from 0 (severe impairment) to 30 (no impairment).†Scores
for the 17-item Hamilton Depression Rating Scale range from 0 to 52, with higher scores indicating more severe depression.‡Scores on the
Neuropsychiatric Inventory range from 0 to 144, with higher scores indicating increased behavioral and psychological symptoms.
between the 3 groups (control, low, and high exercise,
see Supplementary Table 1), however, the proportion of
patients with arterial hypertension was greater in the
low exercise group, and none of the patients treated
with beta-blockers fulfilled the high exercise criteria
as they could not reach the level of more than 70% of
maximal HR during the exercise.
ITT analyses
Mean (±SD) between-group differences in out-
comes at follow-up are shown in Table 2. There was
no significant difference in change from baseline to
follow-up between groups on the primary outcome
(SDMT), although there was a 2.5 point (95% CI –1.1
to 6.1; p = 0.179) difference between the groups in
favor of the intervention group. There was a signifi-
cant difference in the change in total neuropsychiatric
symptoms assessed by NPI by –3.5 points (95% con-
fidence interval [CI], –5.8 to –1.3; p = 0.002) from
baseline to follow-up indicating less severe neuropsy-
chiatric symptoms in the intervention group. The
effect of physical exercise seemed to be driven by an
effect on several of the sub-items of the NPI scale
(Fig. 2). No other secondary outcomes showed signif-
icant between-group differences in the changes from
baseline to follow-up (Table 2).
Per protocol analyses
At follow-up,high exercise subjects (n = 66) differed
from the control group by 4.2 points on the SDMT
(95% CI, 0.5 to 7.9; p = 0.028) (Table 2). The effect of
exercise on NPI remained significant in high exercise
subjects, while no other significant effects were found
on the other secondary outcomes in high exercise sub-
jects relative to the control group. A trend toward a
difference at follow-up in quality of life on the patient-
rated EQ-5D VAS was found in high exercise subjects
relative to the control group (4.5 points, 95% CI, –0.8
to 9.8; p = 0.097).
Drop-out and safety
Ten patients were lost to follow-up. Reasons for
drop-out are listed in Fig. 1. In all, 58 adverse events
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Fig. 2. Difference in changes in neuropsychiatric symptoms
between intervention and control group. Between-Group Differ-
ences in the Change from Baseline on the 12 sub-items of the
Neuropsychiatric Inventory (ITT analysis, mean values, bars denote
95% CI). Negative values indicate less severe symptoms, and pos-
itive values indicate more severe symptoms after 16 weeks of
exercise. No statistical analysis was applied, but the effect of exercise
seemed to be driven by a general effect on several sub-items.
(AE) and 13 serious adverse events (SAE) were
reported (Table 3). One incidence of atrial fibrillation
was observed during a training session in a patient with
no previous history of atrial fibrillation. Although the
most likely scenario was that the increased monitor-
ing during the training session revealed undiagnosed
paroxysmal atrial fibrillation, it cannot be ruled out
that the exercise triggered atrial fibrillation. The most
common AE was musculoskeletal problems, with 16
events being reported, of which only 6 were related to
the study.
DISCUSSION
This is the first rigorously conducted study of
moderate-to-high intensity aerobic exercise in mild
AD. Although the primary outcome was negative, there
are several important findings in the study. Attendance
was high (mean: 84%) and in line with previous studies
showing that aerobic exercise is a feasible and well-
perceived intervention for older adults with AD [13,
30]. Following a supervised 16-week exercise pro-
gram of moderate-to-high intensity, neuropsychiatric
symptoms were significantly less severe. Although our
primary outcome, SDMT, was negative in the ITT anal-
ysis, we found a possible effect on cognition in subjects
adhering to the program. This could suggest that phys-
ical exercise may have an effect on cognition provided
that high attendance and intensity is maintained. We
did not find effects on measures of activities of daily
living, depressive symptoms, or health-related quality
of life. Serious adverse effects were rare and drop-
out rates were low, further indicating the safety and
feasibility of this intervention in patients with mild AD.
The strengths of our study include a meticulous
design, the large number of patients, the supervised
exercise program, a high rate of adherence to the inter-
vention, and the use of validated outcome measures.
Weaknesses include lack of monitoring of the physical
activity in the two groups outside the exercise sessions,
the lack of a social activity program in the control
group, an exploratory per protocol analysis that may
have been underpowered to show statistically signifi-
cant effects, and a selection bias which could mean that
the intervention may not be applicable to all patients
with mild AD.
Our findings of an effect of the intervention on
neuropsychiatric symptoms are interesting, because a
Table 3
Adverse events (AE) and serious adverse events (SAE)
Control Intervention
AE n = 58 Musculoskeletal problems 4 12 (6 related)
Dizziness or faintness 1 10 (6 related)
Symptoms related to AD 4 3
Somatic disease (i.e., cold, anemia, erysipelas) 11 10
Total 20 35
SAE n = 13 Pneumonia 1 1
Urinary tract infection 1
Pulmonary edema 1
Nephrolithiasis 1
Atrial fibrillation 2 (1 possibly related)*
Fracture 2 3
Breast cancer 1
Total 6 7
Numbers of adverse effect and relation to study. ∗One of the serious adverse events were possible related to the study, an atrial fibrillation event
may have been triggered by the intervention.
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recent Cochrane Review concluded that exercise stud-
ies on neuropsychiatric symptoms, which were able to
show a similar effect, were of insufficient quality [9]
though, in that review, some previous low intensity or
multimodal intervention studies were suggestive that
exercise improved neuropsychiatric symptoms [31,
32]. Our findings indicate that physical exercise may
inhibit or delay the emergence of more severe neu-
ropsychiatric symptoms with disease progression. The
difference between the intervention group and the con-
trol group tended to be explained by increasing severity
of already present symptoms in the latter group, which
did not occur in the intervention group. Although not
explicitly tested, there seemed to be a general effect
on neuropsychiatric symptoms, but our study was not
designed to specifically address this issue. We did not
find significant effects on depressive symptoms as mea-
sured by the Hamilton Depression Rating Scale, which
could be due to the low prevalence of depressive symp-
toms at baseline in both groups. We were not able to
test whether the effect on neuropsychiatric symptoms
was mediated by the exercise itself, caregiver relief,
positive expectations concerning the intervention, or
by the social interaction between patients during group
exercise. One could speculate that effects not directly
related to exercise also would have affected other
proxy-rated outcomes, such as quality of life and activ-
ities of daily living, which was not the case, but the
study was not designed to differentiate between the
different aspects of the complex intervention.
The negative findings on other secondary outcomes
such as activities of daily living and quality of life may
have several explanations. The relatively high mean
baseline values on both scales (above 70 on proxy-rated
EQ5D-VAS scale, and ADCS-ADL score of 62 out
of 78 points) may have rendered these outcomes less
sensitive to changes. Another possible explanation for
the discrepant effects on the aforementioned outcomes
and neuropsychiatric symptoms may be that the latter
are more amenable to a short-term intervention, while
an intervention of longer duration is required to affect
quality of life and activities of daily living.
Our results indicated a dose-response of exercise on
our primary outcome since the high exercise subjects
showed less decline on SDMT than the control group
in an exploratory analysis. A dose-dependent neuro-
protective relationship between physical exercise and
cognitive performance could in theory be mediated
through reduction in cardiovascular risk factors [5] or
other neuroprotective changes, including increases in
the brain-derived neurotrophic factor and reductions in
pro-inflammatory cytokines [8, 33, 34]. However, apart
from the exploratory analysis of SDMT, the effect on
cognition was largely negative in this study, and further
studies are warranted before any claim for an effect of
physical exercise on cognition in AD can be made.
Results have been conflicting with regards to which
cognitive domains are most sensitive to exercise.
SDMT was chosen as primary outcome because this
test is sensitive to very early changes in aspects of exec-
utive function (mental speed and attention) in AD [35].
Further, executive function has been considered to be
particularly sensitive to the effect of physical exercise
[36, 37], which recently was corroborated in a large
trial of moderate-intensity exercise in sedentary older
adults where executive function was improved in the
most cognitively impaired subgroup of subjects [6].
Lastly, in a rigorously conducted study in MCI patients
involving moderate-to-high intensity aerobic exercise,
the authors found a positive effect on this test [8].
Therefore, the very modest effect of exercise on cogni-
tive function cannot in all likelihood be accounted for
by the use of an insensitive measure.
The lack of effect on cognition in our ITT analyses
may have several other reasons, including the lack of
adherence to the exercise program in some patients,
as suggested by our per protocol analysis. Although
changes in cognitive function have been demonstrated
in studies with small sample-sizes and different types
of physical exercise, but with a duration similar to ours
[11, 38, 39], it has recently been suggested that at least
six months of exercise is necessary to induce cogni-
tive changes [40]. Thus, the duration of exercise period
may be of importance, as suggested by a recent report
[41]. As judged from the proxy-rated Physical Activity
Scale for the Elderly [42], our patients were less phys-
ically active before entering the study as compared to
healthy older adults [43], but probably more physically
active than the general AD population due to selection
bias. Including physically active patients in the study
may have diminished the possibility of detecting the
beneficial effects of the exercise program.
Furthermore, as we did not monitor the physical
activity levels in the two groups outside the exercise
sessions, we cannot rule out that changes in physical
activity level other than the exercise intervention may
have influenced outcome differences (i.e., participants
in the intervention group being less physically active
between exercise sessions or control group participants
increasing their physical activity during the study).
The potential clinical relevance of our findings
should be judged by the relative modest effect sizes.
For a clinical relevant effect of 4 point or more on
the SDMT, the number needed to treat would be
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25. In contrast, 8 patients would need treatment to
obtain a clinical relevant improvement on NPI (arbi-
trarily defined as –4 point or less). The latter finding
could be relevant as neuropsychiatric symptoms are
associated with increased caregiver distress, increased
admissions to nursing homes, and reduced quality of
life in later stages of AD [12]. Because we selected
patients able and willing to participate in an exercise
program of moderate-to-high intensity, the results may
not necessarily apply to the general AD population.
We chose group exercise due to its cost-effectiveness
and appropriateness for community-based programs.
Interventions combining social interaction with spe-
cific training programs may be optimal, especially for
diseases with complex symptomatology such as AD
[44]. Furthermore, according to feed-back from par-
ticipants, social interaction may at least explain part of
the high adherence to the program.
Considering the potential effect, the few adverse
events of the intervention, and the lack of efficient treat-
ment strategies in AD, there could be a potential for
physical exercise as an add-on therapy in patients with
AD. In particular, given the limited efficacy and high
rate of adverse effects of psychotropic medication [45,
46], as well as the burden of neuropsychiatric symp-
toms [47], the current program could be considered as
an add-on therapy in a community setting.
Future studies should clarify the potential dose-
dependent effect on cognition that we may have
observed in the per protocol analysis. Trying to dis-
entangle the effect of exercise from the effect of social
interaction is another avenue for further study.
Moreover, studies are needed to confirm the findings
from our study, and should also aim at further elucidat-
ing the underlying possible mechanisms of exercise. It
should be clarified whether beneficial effects are symp-
tomatic or disease modifying. Equally as important is
to determine the optimal selection of type, dosage, and
intensity of exercise.
In conclusion, our study shows that even a relatively
short-term intervention can be effective in reducing
neuropsychiatric symptoms of patients with mild AD.
Furthermore, the data suggest that the dose of exercise
impacts the effect on cognition.
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